Expert Insights
ETF Channels
ETF Strategist
Multi-Asset
Smart Beta
Tactical Allocation
Thematic Investing
Alternatives
Leveraged & Inverse
Disruptive Technology
Innovative ETFs
Equity ETF
Retirement ETF
Crypto
ETF Building Blocks
Nasdaq Portfolio Solutions
Model Portfolio
Active ETF
ESG
Multi-Factor
Entrepreneur ETF
ETF 360
ETF Education
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – Invesco QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA – iShares MSCI EAFE ETF
EEM – iShares MSCI Emerging Markets ETF
IEMG – iShares Core MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX – VanEck Vectors Gold Miners ETF
XLF – Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV – Vanguard Value ETF
Top Gold ETFs
Top Oil ETFs
Top Commodity ETFs
Top Hedge Fund ETFs
Top Financials ETFs
Top Inverse Equities ETFs
Top High Yield Bond ETFs
ETF Education
Newsletter
New ETFs
ETF Ecosystem
Education Central
Video
Podcasts
ETF Playbook
Virtual Summit
BBH
Featured
Biotech ETFs Break Out
By
John Spence
January 19, 2012
Featured
Six HOLDRS Become Van Eck ETFs
By
Tom Lydon
December 21, 2011
Featured
HOLDRS Making Transition to Market Vector ETFs
By
Tom Lydon
November 23, 2011
New ETFs
Van Eck, Merrill Lynch in Agreement Over HOLDRS
By
Tom Lydon
August 15, 2011
Featured
Biotech ETFs Mixed After Gilead Subpoena
By
Tom Lydon
June 13, 2011
Featured
Biogen Earnings, Drug Data to Lift Biotech ETFs
By
John Spence
April 21, 2011
Featured
5 Biotechnology ETFs to Play Innovation
By
Tom Lydon
February 22, 2011
Featured
Play the Booming Biotech Sector With ETFs
By
Tom Lydon
December 21, 2010
Featured
Biotech ETFs: 5 Ways to Play Innovation
By
Tom Lydon
August 8, 2010
Featured
5 Biotech ETFs If You’re Bullish
By
Tom Lydon
June 25, 2010
Featured
Why Biotech ETFs May Be the Better Choice
By
Tom Lydon
June 17, 2009
Featured
How Biotech ETFs Can Rise Above Challenges
By
Tom Lydon
May 12, 2009
Featured
How Biotech ETFs Are Overcoming Sector’s Trials
By
Tom Lydon
March 24, 2009
Featured
Midday Market Update: Downgrades and Mergers Lead Markets and ETFs
By
Tom Lydon
March 12, 2009
Featured
What Stem Cell Research Means for Biotech ETFs
By
Tom Lydon
March 10, 2009
Featured
How Obama’s Health Care Reform Impacts Biotech ETFs
By
Tom Lydon
March 5, 2009
Featured
Midday Market Update: Can New Program Spark an ETF Rally?
By
Tom Lydon
March 3, 2009
Featured
Health Care ETFs’ $140 Billion Boost
By
Tom Lydon
February 19, 2009
Previous
1
…
4
5
6
7
Next
X